日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Retraction Note: Expression of liver-targeting peptide modified recombinant human endostatin and preliminary study of its biological activities

撤稿声明:肝脏靶向肽修饰的重组人内皮抑素的表达及其生物活性的初步研究

Ma, Y; Jin, X-B; Chu, F-J; Bao, D-Mei; Zhu, J-Y

The mouth as a window: A multi-center retrospective study of oral extraintestinal manifestations of IBD and their management

口腔是窗口:一项关于炎症性肠病口腔肠外表现及其治疗的多中心回顾性研究

Aristizabal-Torres, M-A; Janovska, M; Loeb, L-P; Ma, Y; Rogers-Iii, R-S; Farraye, F-A; Bruce, A-J; Chedid, V; Hashash, J-G; Bodiford, K-J

Phase I trial of hES cell-derived dopaminergic neurons for Parkinson's disease

利用人胚胎干细胞衍生的多巴胺能神经元治疗帕金森病的I期临床试验

Tabar, V; Sarva, H; Lozano, A M; Fasano, A; Kalia, S K; Yu, K K H; Brennan, C; Ma, Y; Peng, S; Eidelberg, D; Tomishima, M; Irion, S; Stemple, W; Abid, N; Lampron, A; Studer, L; Henchcliffe, C

A phase I dose-escalation and dose-expansion study of tibremciclib, a novel CDK4/6 inhibitor, monotherapy and in combination with fulvestrant in HR-positive/HER2-negative advanced breast cancer

一项针对HR阳性/HER2阴性晚期乳腺癌患者的tibremciclib单药治疗及联合氟维司群治疗的I期剂量递增和剂量扩展研究

Zhang, J; Liu, R; Gao, S; Chen, W; Han, X; Wang, Z; Zhou, H; Wang, Y; Chen, J; Ma, Y; Liu, K; Shen, Z; Ding, L; Li, P; Hu, X

[Efficacy of selinexor combined with subcutaneous decitabine in myeloid malignancies refractory to or relapsed after venetoclax therapy]

[塞利尼索联合皮下注射地西他滨治疗对维奈托克治疗无效或复发的髓系恶性肿瘤的疗效]

Mi, R H; Wang, L; Hu, N; Li, C; Chen, L; Ma, Y X; Wei, X D

Evaluating disability, comorbidities and risk factors after TB treatment: an 18-24 month follow-up

结核病治疗后残疾、合并症和危险因素的评估:18-24个月的随访

Sun, Y; Lin, Y; Golub, J E; Shu, W; Jiang, J; Xu, Q; Li, Y; Sun, W; Shi, Y; Liao, J; Nie, C; Liang, C; Zhang, X; Liu, H; Ma, Y; Zachariah, R; Berger, S D; Thekkur, P; Nair, D; Satyanarayana, S; Kumar, A M V; Harries, A D

Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia

HLA-A2-WT1 CD3双特异性抗体RO7283420治疗复发/难治性急性髓系白血病的剂量递增研究

Hutchings, Martin; Korfi, Koorosh; Montesinos, Pau; Santoro, Armando; Hou, Hsin-An; Martinez-Sanchez, Pilar; Vives, Susana; Galimberti, Sara; Chen, Tsai-Yun; Frigeni, Marco; Garciaz, Sylvain; Salamero Garcia, Olga; Yeh, Su-Peng; Yee, Karen; Esteve, Jordi; Bajel, Ashish; Fleming, Shaun; Bretz, Anne Catherine; Attig, Jan; Sun, Min; Nassiri, Sina; Rutishauser, Tobias; Klein, Christian; Ma, Y May; Schnetzler, Gabriel; Vauleon, Stephanie; Yu, Huixin; Barata, Teresa; Richard, Muriel; Simon, Silke; Hinton, Heather; Keshelava, Nino; Subklewe, Marion

[Clinical analysis of six eosinophilia cases with Löeffler endocarditis as the main clinical feature]

[对6例以勒夫勒氏心内膜炎为主要临床特征的嗜酸性粒细胞增多症病例进行临床分析]

Ma, Y N; Chen, S N; Zhou, B Y; Yang, X F

[Autologous hematopoietic stem cell transplantation with TBE conditioning in patients with primary central nervous system lymphoma]

[自体造血干细胞移植联合TBE预处理治疗原发性中枢神经系统淋巴瘤]

Chen, J L; Ma, Y; Zhao, R Q; Xiao, X B; Chen, X L; Yuan, S Z; Zhao, S H; Lu, Y; Gao, H H; Wang, Y Q; Yin, H; Cheng, N N; Feng, P; Bai, X R; Huang, W R

[Treatment with interferon α-1b, interleukin-2, and thalidomide for persistent RUNX1::RUNX1T1 in a patient with KIT-mutated acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a case report and literature review]

[异基因造血干细胞移植后KIT突变型急性髓系白血病患者持续存在RUNX1::RUNX1T1的病例报告及文献复习:采用干扰素α-1b、白细胞介素-2和沙利度胺治疗]

Mi, R H; Chen, L; Wang, L; Ma, Y X; Fu, Y W; Wei, X D